Australian Statistics on Medicines 2010

Table 1 - Cardiovascular System

CARDIOVASCULAR SYSTEM

C01 - CARDIAC THERAPY
C02 - ANTIHYPERTENSIVES
C03 - DIURETICS
C04 - PERIPHERAL VASODILATORS
C05 - VASOPROTECTIVES
C07 - BETA BLOCKING AGENTS
C08 - CALCIUM CHANNEL BLOCKERS
C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
C10 - LIPID MODIFYING AGENTS PLAIN

C01 - CARDIAC THERAPY
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM CARDIAC THERAPY CARDIAC GLYCOSIDES DIGITALIS GLYCOSIDES
C01AA05	DIGOXIN
	P	1322N	Tablet 250ug	0.25	MG	132,959	1,438,749
	P	2605D	Tablet 62.5ug	0.25	MG	286,828	3,013,389
	P	3164M	Oral solution for children 50ug per mL, 100mL	0.25	MG	499	13,375
ANTIARRHYTHMICS CLASS I AND III
ANTIARRHYTHMICS CLASS IA
C01BA03	DISOPYRAMIDE
	P	2923W	Capsule 100mg	0.40	GM	4,688	130,543
	P	2924X	Capsule 150mg	0.40	GM	2,964	122,300
ANTIARRHYTHMICS CLASS IB
C01BB01	LIGNOCAINE HYDROCHLORIDE
	P	2875H	Injection 100mg in 5mL	3.00	GM	1,580	65,224
	P	2876J	Infusion 500mg in 5mL	3.00	GM	244	8,829
	P	3474W	Injection 100mg in 5mL	3.00	GM	8,374	311,648
C01BB02	MEXILETINE HYDROCHLORIDE
	P	1682M	Capsule 50mg	0.80	GM	3,041	108,930
	P	1683N	Capsule 200mg	0.80	GM	3,019	193,147
ANTIARRHYTHMICS CLASS IC
p>C01BC04	FLECAINIDE ACETATE
	P	1088G	Tablet 50mg 60	0.20	GM	82,875	3,277,969
	P	1090J	Tablet 100mg	0.20	GM	119,487	5,646,619
ANTIARRHYTHMICS CLASS III
C01BD01	AMIODARONE HYDROCHLORIDE
	P	2343H	Tablet 200mg	0.20	GM	259,766	5,662,171
	P	2344J	Tablet 100mg	0.20	GM	119,024	1,794,493
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
ADRENERGIC AGENTS
C01CA24	ADRENALINE
	P	1016L	Injection 1mg in 1mL (1 in 1,000)	0.50	MG	3,001	65,358
	P	3408J	I.M. injection 150ug in 0.3mL single dose auto-injector	0.50	MG	176	34,975
	P	3409K	I.M. injection 300ug in 0.3mL single dose auto-injector	0.50	MG	293	55,005
	P	3451P	Injection 1mg in 1mL (1 in 1,000)	0.50	MG	27,310	555,216
	P	8697R	I.M. injection 150mg in 0.3mL syringe	0.50	MG	23,256	4,519,560
	P	8698T	I.M. injection 300mg in 0.3mL syringe	0.50	MG	50,477	7,928,575
VASODILATORS USED IN CARDIAC DISEASES
ORGANIC NITRATES
C01DA02	GLYCERYL TRINITRATE
	P	1459T	Tablets 600ug 100	2.50	MG	71,986	897,917
	P	1515R	Td pad releasing approx. 5mg per 24 hours	5.00	MG	191,127	5,331,611
	P	1516T	Td pad releasing approx. 10mg per 24 hours	5.00	MG	100,785	3,493,894
	P	3475X	Buccal/sublingual spray (pump pack) 400ug per dose	2.50	MG	20,034	403,302
	P	8010N	Td patch releasing approx. 5mg per 24 hours	5.00	MG	95,532	2,669,618

C01 - CARDIAC THERAPY
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM CARDIAC THERAPY VASODILATORS USED IN CARDIAC DISEASES
	P	8011P	Td patch releasing approx. 10mg per 24 hours	5.00	MG	48,420	1,680,270
	P	8026K	Td patch releasing approx. 1mg per 24 hours	5.00	MG	19,066	661,572
	P	8027L	Td patch releasing approx. 5mg per 24 hours	5.00	MG	7,661	214,493
	P	8028M	Td patch releasing approx. 10mg per 24 hours	5.00	MG	5,567	193,271
	P	8119H	Td patch releasing approx. 15mg per 24 hours	5.00	MG	3,681	129,116
	P	8171C	Buccal/sublingual spray (pump pack) 400ug per dose	2.50	MG	306,803	6,134,174
C01DA08	ISOSORBIDE DINITRATE
	P	2587E	Tablet 10mg	60.00	MG	13,997	189,172
	P	2588F	Sublingual tablet 5mg	20.00	MG	6,539	93,891
C01DA14	ISOSORBIDE MONONITRATE
	P	1558B	Tablets sustained release 60mg 30	40.00	MG	701,708	9,093,970
	P	8273K	Tablets sustained release 120mg 30	40.00	MG	262,318	5,718,960
OTHER VASODILATORS USED IN CARDIAC DISEASES
C01DX16	NICORANDIL
	P	8228C	Tablet 10mg	40.00	MG	165,948	4,032,309
	P	8229D	Tablet 20mg	40.00	MG	77,961	2,446,928
OTHER CARDIAC PREPARATIONS
OTHER CARDIAC PREPARATIONS
C01EB17	IVABRADINE
	A	19957	Tablets 5mg 56	10.00	MG	10,453	—
	A	19958	Tablets 7.5mg 56	10.00	MG	3,008	—

C02 - ANTIHYPERTENSIVES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM ANTIHYPERTENSIVES ANTIADRENERGIC AGENTS CENTRALLY ACTING METHYLDOPA
C02AB01	METHYLDOPA
	P	1629R	Tablet 250mg	1.00	GM	157,296	2,244,163
IMIDAZOLINE RECEPTOR AGONISTS
C02AC01	CLONIDINE
	P	3141H	Tablet 150ug	0.45	MG	31,429	1,202,942
	P	3145M	Tablet 100ug	0.45	MG	108,812	3,142,865
C02AC05	MOXONIDINE
	P	9019Q	Tablet 200mg 30	0.30	MG	190,500	3,903,792
	P	9020R	Tablet 400mg 30	0.30	MG	147,555	4,326,338
ANTIADRENERGIC AGENTS PERIPHERALLY ACTING
ALPHA - ADRENOCEPTOR BLOCKING AGENTS
C02CA01	PRAZOSIN HYDROCHLORIDE
	P	1478T	Tablet 5mg (base)	5.00	MG	123,136	2,598,908
	P	1479W	Tablet 1mg (base)	5.00	MG	324,436	4,064,751
	P	1480X	Tablet 2mg (base)	5.00	MG	188,995	2,825,698
ARTERIOLAR SMOOTH MUSCLE AGENTS ACTING ON
HYDRAZINOPHTHALAZINE DERIVATIVES
C02DB02	HYDRALAZINE HYDROCHLORIDE
	P	1639G	Tablet 50mg	0.10	GM	28,295	484,530
	P	1640H	Tablet 25mg	0.10	GM	33,692	511,939
PYRIMIDINE DERIVATIVES
C02DC01	MINOXIDIL
	P	2313R	Tablet 10mg	20.00	MG	5,505	308,876
OTHER ANTIHYPERTENSIVES
OTHER ANTHIYPERTENSIVES
C02KX02	AMBRISENTAN
	P	9648T	Tablet 5mg 30	7.50	MG	386	1,573,294
	P	9649W	Tablet 10mg 30	7.50	MG	286	1,166,497
C02KX01	BOSENTAN
	P	6429J	Tablet 62.5mg (base) 60	0.25	MG	432	1,674,523
	P	6430K	Tablet 125mg (base) 60	0.25	MG	7,640	31,161,171
C02KX03	SITAXENTAN
	P	9622K	Tablet 100mg 30	0.10	GM	1,288	3,595,952

C03 - DIURETICS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM DIURETICS LOW-CEILING DIURETICS THIAZIDES THIAZIDES PLAIN
C03AA03	HYDROCHLOROTHIAZIDE
	P	1484D	Tablet 25mg	25.00	MG	92,985	1,960,695
LOW-CEILING DIURETICS EXCL. THIAZIDES
SULFONAMIDES PLAIN
C03BA04	CHLORTHALIDONE
	P	1585K	Tablet 25mg	25.00	MG	30,159	409,346
C03BA11	INDAPAMIDE
	P	2436F	Tablet 2.5mg 90	2.50	MG	162,440	2,833,871
	P	8532C	Tablet 1.5mg (sustained release) 90	2.50	MG	380,058	7,325,279
HIGH-CEILING DIURETICS
SULFONAMIDES PLAIN
C03CA02	BUMETANIDE
	A	17855	Tablet 1mg	1.00	MG	6,108	—
C03CA01	FRUSEMIDE
	P	2411X	Oral solution 10mg per mL 30mL	40.00	MG	3,102	56,515
	P	2412Y	Tablet 40mg	40.00	MG	1,232,088	10,838,955
	P	2413B	Injection 20mg in 2mL	40.00	MG	6,920	80,737
	P	2414C	Tablet 20mg	40.00	MG	292,538	2,625,188
	P	2415D	Tablet 500mg	40.00	MG	14,460	263,514
	P	3466K	Injection 20mg in 2mL	40.00	MG	9,158	95,971
ARYLOXYACETIC ACID DERIVATIVES
C03CC01	ETHACRYNIC ACID
	P	8748K	Tablet 25mg	50.00	MG	2,398	445,083
POTASSIUM-SPARING AGENTS
ALDOSTERONE ANTAGONISTS
C03DA04	EPLERENONE
	P	8879H	Tablet 25mg 30	50.00	MG	10,958	1,257,157
	P	8880J	Tablet 50mg 30	50.00	MG	2,094	245,931
C03DA01	SPIRONOLACTONE
	P	2339D	Tablet 25mg	75.00	MG	322,654	3,989,664
	P	2340E	Tablet 100mg	75.00	MG	60,221	1,811,907
OTHER POTASSIUM-SPARING AGENTS
C03DB01	AMILORIDE HYDROCHLORIDE
	P	3109P	Tablet 5mg	10.00	MG	22,634	249,433
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
LOW-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS
C03EA01	HYDROCHLOROTHIAZIDE with AMILORIDE HYDROCHLORIDE
	P	1486F	Tablet 50mg-5mg	—	—	134,091	1,850,634
C03EA01	HYDROCHLOROTHIAZIDE with TRIAMTERENE
	P	1280J	Tablet 25mg-50mg 100	—	—	30,899	397,738

C04 - PERIPHERAL VASODILATORS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM PERIPHERAL VASODILATORS PERIPHERAL VASODILATORS PURINE DERIVATIVES
C04AD03	OXPENTIFYLLINE
	A	17632	Tablet 400mg 50	1.00	GM	732	—
OTHER PERIPHERAL VASODILATORS
C04AX02	PHENOXYBENZAMINE HYDROCHLORIDE
	P	1862B	Capsule 10mg 30	30.00	MG	215	14,296
	P	9286R	Capsule 10mg 100	30.00	MG	1,615	2,060,783

C05 - VASOPROTECTIVES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM VASOPROTECTIVES AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE CORTICOSTEROIDS
C05AA01	HYDROCORTISONE with CINCHOCAINE HYDROCHLORIDE
	P	4036K	Ointment 5mg-5mg per g (0.5%-0.5%) 30g	—	—	6,868	149,011
C05AA01	HYDROCORTISONE, CINCHOCAINE HYDROCHLORIDE
	A	14345	Ointment 5mg-5mg-10mg per g (0.5%-0.5%-1%)	—	—	3,755	—
	P	4038M	Suppositories 5mg-5mg 12	—	—	7,356	156,032
C05AA01	HYDROCORTISONE, LIGNOCAINE BASE, ALUMINIUM SUBACETATE and ZINC OXIDE
	A	14653	Ointment 2.5mg-50mg-35mg-180mg per g	—	—	1,660	—
C05AA04	PREDNISOLONE HEXANOATE, CINCHOCAINE HYDROCHLORIDE and CLEMIZOLE UNDECYLENATE
	A	14656	Ointment 1.9mg-5mg-10mg per g (0.16-0.5%-1%)	—	—	13,387	—
	A	14657	Ointment 1.9mg-5mg-10mg per g (0.195-0.5%-1%)	—	—	14,218	—
	A	14658	Suppositories 1.3mg-1mg-5mg 12	—	—	8,901	—
LOCAL ANESTHETICS
C05AD03	ADRENALINE EPHEDRINE BENZOCAINE ZINC OXIDE
	A	13134	Ointment 50g 1	—	—	2,241	—
MUSCLE RELAXANTS
C05AE01	GLYCERYL TRINITRATE
	A	16349	Ointment 0.2% 30g 1	—	—	1,575	—
	A	20786	Ointment 0.2% 15g 1	—	—	253	—
OTHER AGENTS FOR TREATMENT HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AX04	ZINC OXIDE
	P	4039N	Compound ointment 50g	—	—	2,424	34,967
	P	4040P	Compound suppositories, 12	—	—	1,535	21,300
ANTIVARICOSE THERAPY
HEPARINS OR HEPARINOIDS FOR TOPICAL USE
C05BA01	HEPARINOID
	A	12829	Cream 0.3%40g 1	—	—	285	—
	A	13774	Cream 0.3% 20g 1	—	—	807	—
CAPILLARY STABILIZING AGENTS
BIOFLAVONOIDS
C05CA02	HYDROXYETHYLRUTOSIDES
	A	16101	Capsule 250mg 100	—	—	196	—

C07 - BETA BLOCKING AGENTS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM BETA BLOCKING AGENTS BETA BLOCKING AGENTS PLAIN BETA BLOCKING AGENTS PLAIN NON-SELECTIVE
C07AA02	OXPRENOLOL HYDROCHLORIDE
	P	2942W	Tablet 20mg	0.16	GM	1,495	14,944
	P	2961W	Tablet 40mg	0.16	GM	9,715	116,971
C07AA03	PINDOLOL
	P	3062E	Tablet 5mg	15.00	MG	19,546	224,792
	P	3065H	Tablet 15mg	15.00	MG	18,548	258,302
C07AA05	PROPRANOLOL HYDROCHLORIDE
	P	2565B	Tablet 10mg	0.16	GM	150,143	1,533,584
	P	2566C	Tablet 40mg	0.16	GM	306,362	3,248,736
	P	2899N	Tablet 160mg	0.16	GM	27,428	304,408
C07AA07	SOTALOL HYDROCHLORIDE
	P	2043M	Tablet 160mg	0.16	GM	102,325	2,741,733
	P	8398B	Tablet 80mg 60	0.16	GM	371,629	5,902,847
BETA BLOCKING AGENTS PLAIN SELECTIVE
C07AB03	ATENOLOL
	P	1081X	Tablet 50mg	0.08	GM	3,989,016	42,644,232
	A	21266	Tablet 50mg 30	0.08	GM	234	—
C07AB07	BISOPROLOL
	P	8604W	Tablet 2.5mg	10.00	MG	203,461	10,372,590
	P	8605X	Tablet 5mg	10.00	MG	191,063	11,812,109
	P	8606Y	Tablet 10mg	10.00	MG	159,425	11,688,592
C07AB02	METOPROLOL SUCCINATE
	P	8732N	Tablet 23.75mg (controlled release) 15	150.00	MG	9,742	316,036
	P	8733P	Tablet 47.5mg (controlled release) 30	150.00	MG	38,863	2,901,711
	P	8734Q	Tablet 95mg (controlled release) 30	150.00	MG	38,423	3,516,685
	P	8735R	Tablet 190mg (controlled release) 30	150.00	MG	29,129	3,212,038
C07AB02	METOPROLOL TARTRATE
	P	1324Q	Tablet 50mg	150.00	MG	1,311,952	14,142,912
	P	1325R	Tablet 100mg	150.00	MG	446,511	5,403,151
C07AB12	NEBIVOLOL
	P	9310B	Tablet 1.25mg (as hydrochloride), 28	5.00	MG	1,524	45,278
	P	9311C	Tablet 5mg (as hydrochloride) 28	5.00	MG	3,286	202,635
	P	9312D	Tablet 10mg (as hydrochloride) 28	5.00	MG	1,357	91,825
	P	9316H	Tablet 1.25mg (as hydrochloride) 28	5.00	MG	1,068	43,674
ALPHA- AND BETA- ADRENOCEPTOR BLOCKING AGENTS
C07AG02	CARVEDILOL
	P	8255L	Tablet 3.125mg 30	37.50	MG	31,581	695,415
	P	8256M	Tablet 6.25mg	37.50	MG	123,097	6,452,233
	P	8257N	Tablet 12.5mg	37.50	MG	149,378	9,443,371
	P	8258P	Tablet 25mg	37.50	MG	267,394	21,279,528
C07AG01	LABETALOL HYDROCHLORIDE
	P	1566K	Tablet 100mg	0.60	GM	19,619	305,061

- BETA BLOCKING AGENTS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM BETA BLOCKING AGENTS BETA BLOCKING AGENTS PLAIN
	P	1567L	Tablet 200mg	0.60	GM	21,000	476,884

C08 - CALCIUM CHANNEL BLOCKERS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS DIHYDROPYRIDINE DERIVATIVES
C08CA01	AMLODIPINE
	P	1343Q	Tablet 5mg (base) maleate salt 30	5.00	MG	278,933	4,648,928
	P	1345T	Tablet 10mg (base) maleate salt 30	5.00	MG	213,012	5,192,501
	P	2751T	Tablet 5mg (base) besylate salt 3 0	5.00	MG	1,387,227	23,296,695
	P	2752W	Tablet 10mg (base) besylate salt 30	5.00	MG	1,130,870	27,759,353
C08CA02	FELODIPINE
	P	2361G	Tablet 2.5mg (extended release)	5.00	MG	192,394	2,560,347
	P	2366M	Tablet 5mg (extended release)	5.00	MG	461,259	7,434,850
	P	2367N	Tablet 10mg (extended release)	5.00	MG	559,939	13,933,248
C08CA13	LERCANIPIDINE
	P	8534E	Tablet 10mg 30	10.00	MG	1,102,943	21,455,024
	P	8679T	Tablet 20mg 30	10.00	MG	912,851	25,555,152
	P	8939L	Tablet 10mg 30	10.00	MG	66,790	1,725,225
	P	8940M	Tablet 20mg 30	10.00	MG	83,506	2,902,181
C08CA05	NIFEDIPINE
	P	1694E	Tablet 10mg 60	30.00	MG	35,164	560,927
	P	1695F	Tablet 20mg 60	30.00	MG	32,604	604,869
	P	1906H	Tablet 30mg (controlled release) 30	30.00	MG	330,075	6,373,543
	P	1907J	Tablet 60mg (controlled release) 30	30.00	MG	315,002	7,325,032
	P	8610E	Tablet 20mg (controlled release) 30	30.00	MG	122,823	2,264,191
	P	8938K	Tablet 20mg (controlled release) 30	30.00	MG	5,670	134,292
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
PHENYLALKYLAMINE DERIVATIVES
C08DA01	VERAPAMIL HYDROCHLORIDE
	P	1241H	Tablet 240mg (sustained release)	0.24	GM	580,712	9,696,291
	P	1248Q	Tablet 40mg	0.24	GM	32,792	377,120
	P	1250T	Tablet 80mg	0.24	GM	30,765	473,847
	P	1253Y	Tablet 160mg	0.24	GM	12,980	242,643
	P	1254B	Tablet 120mg	0.24	GM	6,397	124,548
	P	2206D	Capsule 160mg (sustained release)	0.24	GM	56,639	727,306
	P	2207E	Capsule 240mg (sustained release)	0.24	GM	102,517	1,705,728
	P	2208F	Capsule 180mg (sustained release)	0.24	GM	219,683	3,109,265
	P	3494X	Injection 5mg in 2mL	0.24	GM	3,617	44,761
BENZOTHIAZEPINE DERIVATIVES
C08DB01	DILTIAZEM HYDROCHLORIDE
	P	1312C	Capsule 180mg controlled delivery	0.24	GM	481,000	8,328,539
	P	1313D	Capsule 240mg controlled delivery	0.24	GM	463,978	9,798,937
	P	1335G	Tablet 60mg	0.24	GM	53,123	865,472
	P	8480H	Capsule 360mg controlled delivery 30	0.24	GM	303,987	7,786,081
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
C08EX02	PERHEXILINE MALEATE

- CALCIUM CHANNEL BLOCKERS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
	P	1822X	Tablet 100mg	0.20	GM	30,561	1,917,786

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, PLAIN CONVERTING ENZYME BLOCKERS
C09AA01	CAPTOPRIL
	P	1147J	Tablet 12.5mg	50.00	MG	5,580	92,604
	P	1148K	Tablet 25mg	50.00	MG	19,536	416,170
	P	1149L	Tablet 50mg	50.00	MG	31,770	1,154,787
	P	8760C	Oral solution 5mg per mL 95mL	50.00	MG	1,036	126,248
C09AA02	ENALAPRIL MALEATE
	P	1368B	Tablet 10mg	10.00	MG	157,278	2,847,230
	P	1369C	Tablet 20mg	10.00	MG	309,194	7,323,042
	P	1370D	Tablet 5mg	10.00	MG	71,211	951,339
C09AA09	FOSINOPRIL
	P	1182F	Tablet 10mg 30	15.00	MG	115,062	1,818,439
	P	1183G	Tablet 20mg	15.00	MG	217,661	4,803,187
C09AA03	LISINOPRIL
	P	2456G	Tablet 5mg 30	10.00	MG	95,704	1,361,486
	P	2457H	Tablet 10mg 30	10.00	MG	186,499	3,394,932
	P	2458J	Tablet 20mg 30	10.00	MG	344,926	7,801,925
C09AA04	PERINDOPRIL
	P	3050M	Tablet 2mg (erbumine) 30	4.00	MG	357,781	4,543,254
	P	3051N	Tablet 4mg (erbumine) 30	4.00	MG	647,918	11,734,742
	P	8704D	Tablet 8mg (erbumine) 30	4.00	MG	579,745	14,091,947
	P	9006B	Tablet 2.5mg (arginine) 30	4.00	MG	745,642	9,421,151
	P	9007C	Tablet 5mg (arginine) 30	4.00	MG	1,629,001	29,631,188
	P	9008D	Tablet 10mg (arginine) 30	4.00	MG	1,586,693	38,728,631
C09AA06	QUINAPRIL
	P	1968N	Tablet 5mg (as hydrochloride) 30	15.00	MG	35,534	498,717
	P	1969P	Tablet 10mg (as hydrochloride) 30	15.00	MG	96,682	1,681,182
	P	1970Q	Tablet 20mg (as hydrochloride) 30	15.00	MG	207,234	4,437,206
C09AA05	RAMIPRIL
	P	1316G	Tablet 10mg 30	2.50	MG	166,191	3,949,718
	P	1944H	Capsule 1.25mg 28	2.50	MG	157,272	1,824,795
	P	1945J	Capsule 2.5mg 28	2.50	MG	526,240	7,359,887
	P	1946K	Capsule 5.0mg 28	2.50	MG	1,006,771	16,304,367
	P	8470T	Capsule 10mg 30	2.50	MG	1,545,064	36,072,167
	P	8668F	Pack 7 Tabs 2.5mg 21 tabs 5mg and 10 caps 10mg	2.50	MG	1,259	27,764
	P	9120B	Capsule 1.25mg 30	2.50	MG	5,683	65,844
	P	9121C	Capsule 2.5mg 30	2.50	MG	20,861	286,144
	P	9122D	Capsule 5.0mg 30	2.50	MG	30,252	481,855
C09AA10	TRANDOLAPRIL
	P	2791X	Capsule 500ug	2.00	MG	22,460	213,598
	P	2792Y	Capsule 1mg	2.00	MG	70,052	1,002,060
	P	2793B	Capsule 2mg	2.00	MG	159,122	2,596,394
	P	8758Y	Capsule 4mg 28	2.00	MG	156,096	3,808,999

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ACE INHIBITORS, COMBINATIONS ACE INHIBITORS, COMBINATIONS
ANGIOTENSIN-CONVERTING ENZYME BLOCKERS AND DIURETICS
C09BA02	ENALAPRIL with HYDROCHLOROTHIAZIDE
	P	8477E	Tablet 20mg-6mg	—	—	138,137	3,995,318
C09BA09	FOSINOPRIL with HYDROCHLOROTHIAZIDE
	P	8400D	Tablet 10mg-12.5mg	—	—	61,163	1,337,188
	P	8401E	Tablet 20mg-12.5mg	—	—	379,461	11,108,634
C09BA04	PERINDOPRIL with INDAPAMIDE
	P	2190G	Tablet 2.5mg (arginine)-0.625mg 30	—	—	48,111	790,202
	P	2845R	Tablet 5mg (arginine)-1.25mg 30	—	—	1,335,768	39,579,138
	P	8449Q	Tablet 4mg (erbumine)-1.25mg 30	—	—	425,056	12,312,778
C09BA06	QUINAPRIL with HYDROCHLOROTHIAZIDE
	P	8589C	Tablet 10mg(base) / 12.5mg 30	—	—	16,479	322,027
	P	8590D	Tablet 20mg(base) / 12.5mg 30	—	—	92,734	2,052,762
ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS
C09BB02	ENALAPRIL and LERCANIDIPINE
	P	9144G	Tablet 10mg-10mg 30	—	—	39,177	1,227,704
	P	9145H	Tablet 10mg-20mg 30	—	—	81,299	2,744,295
C09BB04	PERINDOPRIL and AMLODIPINE
	P	9346X	Tablet 5mg-5mg 30	—	—	26,336	746,299
	P	9347Y	Tablet 5mg-10mg 30	—	—	8,171	294,540
	P	9348B	Tablet 10mg-5mg 30	—	—	43,572	1,504,620
	P	9349C	Tablet 10mg-10mg 30	—	—	35,088	1,475,784
C09BB05	RAMIPRIL and FELODIPINE
	P	2626F	Tablet 2.5mg-2.5mg 30	—	—	9,306	195,885
	P	2629J	Tablet 5mg-5mg 30	—	—	75,050	2,081,743
C09BB10	TRANDOLAPRIL and VERAPAMIL
	P	2857J	Tablet 4mg-240mg (sustained release) 28	—	—	61,894	2,060,676
	P	9387C	Tablet 2mg-180mg (sustained release) 28	—	—	10,805	248,060
ANGIOTENSIN II ANTAGONISTS
ANGIOTENSIN II ANTAGONISTS PLAIN
C09CA06	CANDESARTAN
	P	8295N	Tablet 4mg 30	8.00	MG	295,938	5,824,516
	P	8296P	Tablet 8mg 30	8.00	MG	867,849	20,234,251
	P	8297Q	Tablet 16mg 30	8.00	MG	1,064,810	31,423,236
	P	8889W	Tablet 32mg 30	8.00	MG	553,249	25,859,326
C09CA02	EPROSARTAN
	P	8397Y	Tablet 400mg (base) 56	0.60	GM	23,227	674,369
	P	8447N	Tablet 600mg (base) 28	0.60	GM	77,018	2,382,084
	P	8951D	Tablet 400mg (base) 56	0.60	GM	621	19,350
C09CA04	IRBESARTAN
	P	8246B	Tablet 75mg	150.00	MG	573,668	12,149,834
	P	8247C	Tablet 150mg	150.00	MG	1,699,398	42,938,847

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II ANTAGONISTS
	P	8248D	Tablet 300mg	150.00	MG	1,931,857	58,799,343
C09CA01	LOSARTAN
	A	16073	Tablet 50mg 30	0.05	GM	2,019	—
C09CA08	OLMESARTAN MEDOXOMIL
	P	2147B	Tablet 20mg 30	20.00	MG	239,264	6,037,780
	P	2148C	Tablet 40mg 30	20.00	MG	201,322	6,270,209
C09CA07	TELMISARTAN
	P	8355R	Tablet 40mg	40.00	MG	1,213,557	26,343,751
	P	8356T	Tablet 80mg	40.00	MG	1,207,920	35,171,829
C09CA03	VALSARTAN
	P	9368C	Tablet 40mg 28	80.00	MG	3,324	53,687
	P	9369D	Tablet 80mg 28	80.00	MG	43,162	870,267
	P	9370E	Tablet 160mg 28	80.00	MG	25,240	608,539
	P	9371F	Tablet 320mg 28	80.00	MG	7,219	206,665
ANGIOTENSIN II ANTAGONISTS COMBINATIONS
ANGIOTENSIN II ANTAGONISTS AND DIURETICS
C09DA06	CANDESARTAN with HYDROCHLOROTHIAZIDE
	P	8504N	Tablet 16mg-12.5mg 30	—	—	1,053,194	33,487,645
	P	9314F	Tablet 32mg-12.5mg 30	—	—	78,166	3,790,042
	P	9315G	Tablet 32mg-25mg 30	—	—	34,115	1,720,543
C09DA02	EPROSARTAN with HYDROCHLOROTHIAZIDE
	P	8624X	Tablet 600mg (base) -12.5mg 28	—	—	90,259	2,931,130
C09DA04	IRBESARTAN with HYDROCHLOROTHIAZIDE
	P	2136K	Tablet 300mg-25mg 30	—	—	447,763	15,524,459
	P	8404H	Tablet 150mg-12.5mg 30	—	—	698,856	19,112,038
	P	8405J	Tablet 300mg-12.5mg 30	—	—	2,281,690	74,100,927
C09DA08	OLMESARTAN with HYDROCHLOROTHIAZIDE
	P	2161R	Tablet 20mg 12.5mg 30	—	—	62,820	1,715,894
	P	2166B	Tablet 40mg 12.5mg 30	—	—	140,175	4,545,893
	P	2170F	Tablet 40mg 25mg 30	—	—	122,831	4,258,612
C09DA07	TELMISARTAN with HYDROCHLOROTHIAZIDE
	P	8622T	Tablet 40mg-12.5mg 28	—	—	262,526	6,222,511
	P	8623W	Tablet 80mg-12.5mg 28	—	—	1,009,664	31,276,557
	P	9381R	Tablet 80mg-25mg 28	—	—	146,857	4,855,527
C09DA03	VALSARTAN with HYDROCHLOROTHIAZIDE
	P	9372G	Tablet 80mg-12.5mg 28	—	—	5,659	125,149
	P	9373H	Tablet 160mg-12.5mg 28	—	—	9,796	254,988
	P	9374J	Tablet 160mg-25mg 28	—	—	5,275	147,971
	P	9481B	Tablet 320mg-12.5mg 28	—	—	3,133	96,387
	P	9482C	Tablet 320mg-25mg 28	—	—	2,461	80,541
ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS
C09DB01	AMLODIPINE and VALSARTAN
	P	9375K	Tablet 5mg as (besylate)-80mg 28	—	—	47,571	1,415,708

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM ANGIOTENSIN II ANTAGONISTS COMBINATIONS
	P	9376L	Tablet 5mg as (besylate)-160mg 28	—	—	93,828	3,148,113
	P	9377M	Tablet 10mg as (besylate)-160mg 28	—	—	107,120	4,356,017
C09DB02	OLMESARTAN with AMLODIPINE
	P	5292M	Tablet containing olmesartan medoxomil 20mg with amlodipine 5mg (as besylate)	—	—	387	13,639
	P	5293N	Tablet containing olmesartan medoxomil 40mg with amlodipine 5mg (as besylate)	—	—	692	28,099
	P	5294P	Tablet containing olmesartan medoxomil 40mg with amlodipine 10mg (as besylate)	—	—	588	27,754
ANGIOTENSIN II ANTAGONISTS OTHER COMBINATIONS
C09DX01	AMLODIPINE with VALSARTAN and HYDROCHLOROTHIAZIDE
	P	5285E	Tablet 5mg (as besylate)-160mg-12.5mg	—	—	738	26,236
	P	5286F	Tablet 5mg (as besylate)-160mg-25mg	—	—	219	8,232
	P	5287G	Tablet 10mg (as besylate)-160mg-12.5mg	—	—	779	33,065
	P	5288H	Tablet 10mg (as besylate)-160mg-25mg	—	—	300	13,264
	P	5289J	Tablet 10mg (as besylate)-320mg-25mg	—	—	398	19,187

C10 - LIPID MODIFYING AGENTS PLAIN
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS PLAIN LIPID MODIFYING AGENTS PLAIN HMG REDUCTASE INHIBITORS
C10AA05	ATORVASTATIN
	P	8213G	Tablet 10mg (as calcium) 30	20.00	MG	1,672,552	71,287,889
	P	8214H	Tablet 20mg (as calcium) 30	20.00	MG	3,685,770	213,541,726
	P	8215J	Tablet 40mg (as calcium) 30	20.00	MG	3,994,901	315,634,981
	P	8521L	Tablet 80mg (as calcium) 30	20.00	MG	1,431,636	157,631,739
	P	9230T	Tablet 10mg (as calcium) 30	20.00	MG	43,825	1,867,293
	P	9231W	Tablet 20mg (as calcium) 30	20.00	MG	99,500	5,763,631
	P	9232X	Tablet 40mg (as calcium) 30	20.00	MG	121,521	9,598,079
	P	9233Y	Tablet 80mg (as calcium) 30	20.00	MG	49,605	5,459,707
C10AA04	FLUVASTATIN
	P	2863Q	Tablet 80mg (as sodium) (prolonged release) 28	60.00	MG	21,974	1,021,333
	P	8023G	Capsule 20mg (as sodium) 28	60.00	MG	25,341	661,636
	P	8024H	Capsule 40mg (as sodium) 28	60.00	MG	36,676	1,152,902
	P	9234B	Capsule 20mg (as sodium) 28	60.00	MG	659	17,179
	P	9235C	Capsule 40mg (as sodium) 28	60.00	MG	1,008	34,093
	P	9236D	Capsule 80mg (as sodium) 28	60.00	MG	992	46,078
C10AA03	PRAVASTATIN
	A	21311	Tablet 10mg 30	30.00	MG	228	—
	P	2833D	Tablet 10mg 30	30.00	MG	80,856	1,740,269
	P	2834E	Tablet 20mg 30	30.00	MG	315,290	9,618,546
	P	8197K	Tablet 40mg 30	30.00	MG	659,955	28,728,181
	P	8829Q	Tablet 80mg 30	30.00	MG	134,982	8,296,308
	P	9237E	Tablet 10mg 30	30.00	MG	2,509	53,719
	P	9238F	Tablet 20mg 30	30.00	MG	10,703	326,201
	P	9239G	Tablet 40mg 30	30.00	MG	19,025	827,638
	P	9240H	Tablet 80mg 30	30.00	MG	6,663	409,613
C10AA07	ROSUVASTATIN
	P	3402C	Tablet 5mg (as calcium) 30	10.00	MG	5,393	245,898
	P	3403D	Tablet 10mg (as calcium) 30	10.00	MG	9,757	607,468
	P	3404E	Tablet 20mg (as calcium) 30	10.00	MG	5,302	455,368
	P	3405F	Tablet 40mg (as calcium) 30	10.00	MG	2,629	315,214
	P	9042X	Tablet 5mg (as calcium) 30	10.00	MG	885,445	41,460,046
	P	9043Y	Tablet 10mg (as calcium) 30	10.00	MG	2,668,036	170,882,212
	P	9044B	Tablet 20mg (as calcium) 30	10.00	MG	1,264,015	111,621,059
	P	9045C	Tablet 40mg (as calcium) 30	10.00	MG	581,923	71,686,089
C10AA01	SIMVASTATIN
	P	2011W	Tablet 10mg	30.00	MG	472,339	11,805,259
	P	2012X	Tablet 20mg	30.00	MG	1,502,294	49,799,827
	P	2013Y	Tablet 5mg	30.00	MG	24,075	477,587
	P	8173E	Tablet 40mg	30.00	MG	2,047,450	90,898,071
	P	8313M	Tablet 80mg	30.00	MG	559,559	33,215,158
	P	9241J	Tablet 5mg 30	30.00	MG	814	16,187

C10 - LIPID MODIFYING AGENTS PLAIN
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS PLAIN LIPID MODIFYING AGENTS PLAIN
	P	9242K	Tablet 10mg 30	30.00	MG	15,066	376,631
	P	9243L	Tablet 20mg 30	30.00	MG	44,377	1,469,966
	P	9244M	Tablet 40mg 30	30.00	MG	62,263	2,762,581
	P	9245N	Tablet 80mg 30	30.00	MG	23,101	1,370,274
FIBRATES
C10AB05	FENOFIBRATE
	P	9022W	Tablet 48mg 60	0.20	GM	42,000	1,258,323
	P	9023X	Tablet 145mg 30	0.20	GM	555,856	23,170,458
	P	9246P	Tablet 48mg 60	0.20	GM	2,166	64,990
	P	9247Q	Tablet 145mg 30	0.20	GM	18,847	786,589
C10AB04	GEMFIBROZIL
	P	1453L	Tablet 600mg	1.20	GM	186,770	5,547,647
	P	9248R	Tablet 600mg 60	1.20	GM	4,164	123,688
BILE ACID SEQUESTRANTS
C10AC02	COLESTIPOL HYDROCHLORIDE
	P	1224K	Sachets 5g 120	20.00	GM	1,005	76,133
C10AC01	COLESTYRAMINE
	P	2967E	Sachets 4.7g (equiv to 4g cholestyramine)	14.00	GM	33,347	2,107,303
	P	9249T	Sachets 4.7g (equiv to 4g cholestyramine) 50, 2	14.00	GM	1,923	122,991
NICOTINIC ACID AND DERIVATIVES
C10AD02	NICOTINIC ACID
	A	19191	Tablet 250mg	2.00	GM	3,589	—
OTHER LIPID MODIFYING AGENTS
C10AX09	EZETIMIBE
	P	8757X	Tablet 10mg 30	10.00	MG	992,309	70,580,724
LIPID MODIFYING AGENTS COMBINATIONS
HMG COA REDUCTASE INHIBITORS IN COMBINATION WITH OTHER LIPID MOD AGENTS
C10BA02	SIMVASTATIN and EZETIMIBE
	P	8881K	Tablet 40mg-10mg 30	—	—	351,582	37,893,027
	P	8882L	Tablet 80mg-10mg 30	—	—	322,609	39,972,235
	P	9483D	Tablet 10mg-10mg 30	—	—	10,537	935,164
	P	9484E	Tablet 10mg-20mg 30	—	—	14,156	1,365,656
HMG COA REDUCTASE INHIBITORS, OTHER COMBINATIONS
C10BX03	ATORVASTATIN and AMLODIPINE
	P	9049G	Tablet 10mg (base) 5mg (base) 30	—	—	81,212	4,187,140
	P	9050H	Tablet 20mg (base) 5mg (base) 30	—	—	184,749	12,517,604
	P	9051J	Tablet 40mg (base) 5mg (base) 30	—	—	196,592	17,462,585
	P	9052K	Tablet 80mg (base) 5mg (base) 30	—	—	66,680	8,000,743
	P	9053L	Tablet 10mg (base) 10mg (base) 30	—	—	58,068	3,398,053
	P	9054M	Tablet 20mg (base) 10mg (base) 30	—	—	160,468	12,066,603
	P	9055N	Tablet 40mg (base) 10mg (base) 30	—	—	210,049	20,215,075
	P	9056P	Tablet 80mg (base) 10mg (base) 30	—	—	85,130	10,842,524

Australian Statistics on Medicines 2010

Table 1 - Cardiovascular System

Department of Health and Aged Care

Pharmaceutical Benefits Scheme

PBS Information

Browse the PBS

For Health Professionals

For Industry